Literature DB >> 21683398

Implantation of autologous urine derived stem cells expressing vascular endothelial growth factor for potential use in genitourinary reconstruction.

Shaofeng Wu1, Zhan Wang, Shantaram Bharadwaj, Steven J Hodges, Anthony Atala, Yuanyuan Zhang.   

Abstract

PURPOSE: We evaluated the effects of vascular endothelial growth factor overexpression on urine derived stem cell survival and myogenic differentiation to determine whether these cells could be used as a novel cell source for genitourinary reconstruction.
MATERIALS AND METHODS: Urine derived stem cells were isolated from 31 urine samples of 6 healthy individuals 3 to 27 years old. Urine derived stem cells were infected with an adenoviral vector containing the mouse VEGF gene. These cells were then mixed with human umbilical vein endothelial cells (total 5×10(6)) in a collagen-I gel. These cell containing gels were subcutaneously implanted along with 6 other controls into 18 athymic mice. The grafts were assessed up to 28 days after injection for gross appearance and immunocytochemistry.
RESULTS: Vascular endothelial growth factor levels in the media from infected urine derived stem cell cultures reached a peak value on day 10 after infection. Grafts composed of urine derived stem cell/adenoviral vector containing the mouse VEGF gene and human umbilical vein endothelial cells were larger and better vascularized compared to uninfected urine derived stem cell control grafts. Additionally more implanted cells expressed human nuclear markers in the vascular endothelial growth factor expressing grafts. Vascular endothelial growth factor expressing grafts also contained more cells expressing the endothelial markers CD-31 and von Willebrand factor, and smooth muscle markers (α-smooth muscle actin, desmin and myosin). Also, more nerve fibers were present in urine derived stem cell/adenoviral vector containing mouse VEGF gene plus human umbilical vein endothelial cell grafts than in controls.
CONCLUSIONS: Vascular endothelial growth factor overexpression combined with human umbilical vein endothelial cells enhanced in vivo survival and myogenic differentiation of urine derived stem cells. Neovascularization and nerve regeneration were also enhanced within the implanted grafts.
Copyright © 2011 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21683398     DOI: 10.1016/j.juro.2011.03.152

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  26 in total

Review 1.  Virus integration and genome influence in approaches to stem cell based therapy for andro-urology.

Authors:  Longkun Li; Deying Zhang; Peng Li; Margot Damaser; Yuanyuan Zhang
Journal:  Adv Drug Deliv Rev       Date:  2014-10-18       Impact factor: 15.470

Review 2.  Urine-derived stem cells: applications in skin, bone and articular cartilage repair.

Authors:  Wenqian Zhang; Jungen Hu; Yizhou Huang; Chenyu Wu; Huiqi Xie
Journal:  Burns Trauma       Date:  2021-11-26

3.  3D Spheroids of Human Primary Urine-Derived Stem Cells in the Assessment of Drug-Induced Mitochondrial Toxicity.

Authors:  Huifen Ding; Kalyani Jambunathan; Guochun Jiang; David M Margolis; Iris Leng; Michael Ihnat; Jian-Xing Ma; Jon Mirsalis; Yuanyuan Zhang
Journal:  Pharmaceutics       Date:  2022-05-11       Impact factor: 6.525

Review 4.  The potential role of stem cells in the treatment of urinary incontinence.

Authors:  Christine Tran; Margot S Damaser
Journal:  Ther Adv Urol       Date:  2015-02

5.  A cocktail of growth factors released from a heparin hyaluronic-acid hydrogel promotes the myogenic potential of human urine-derived stem cells in vivo.

Authors:  Guihua Liu; Rongpei Wu; Bin Yang; Yingai Shi; Chunhua Deng; Anthony Atala; Steven Mou; Tracy Criswell; Yuanyuan Zhang
Journal:  Acta Biomater       Date:  2020-02-08       Impact factor: 8.947

Review 6.  What is the current role of intracavernosal injection in management of erectile dysfunction?

Authors:  A I El-Sakka
Journal:  Int J Impot Res       Date:  2016-04-14       Impact factor: 2.896

Review 7.  Human Urine as a Noninvasive Source of Kidney Cells.

Authors:  Fanny Oliveira Arcolino; Agnès Tort Piella; Elli Papadimitriou; Benedetta Bussolati; Daniel J Antonie; Patricia Murray; Lamberthus van den Heuvel; Elena Levtchenko
Journal:  Stem Cells Int       Date:  2015-05-18       Impact factor: 5.443

8.  Self-renewal and differentiation capacity of urine-derived stem cells after urine preservation for 24 hours.

Authors:  Ren Lang; Guihua Liu; Yingai Shi; Shantaram Bharadwaj; Xiaoyan Leng; Xiaobo Zhou; Hong Liu; Anthony Atala; Yuanyuan Zhang
Journal:  PLoS One       Date:  2013-01-18       Impact factor: 3.240

Review 9.  Towards a Treatment of Stress Urinary Incontinence: Application of Mesenchymal Stromal Cells for Regeneration of the Sphincter Muscle.

Authors:  Wilhelm K Aicher; Melanie L Hart; Jan Stallkamp; Mario Klünder; Michael Ederer; Oliver Sawodny; Martin Vaegler; Bastian Amend; Karl D Sievert; Arnulf Stenzl
Journal:  J Clin Med       Date:  2014-02-24       Impact factor: 4.241

10.  Urine is a novel source of autologous mesenchymal stem cells for patients with epidermolysis bullosa.

Authors:  Markus Schosserer; Rita Reynoso; Verena Wally; Bogdan Jug; Viktoria Kantner; Sylvia Weilner; Ivana Buric; Johannes Grillari; Johann W Bauer; Regina Grillari-Voglauer
Journal:  BMC Res Notes       Date:  2015-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.